All News
STAT+: Cytokinetics is not looking to be acquired, CEO says
The CEO of Cytokinetics says the company is not for sale. That doesn't mean it would turn away potential suitors.
Read MoreWhat does AI plan mean for NHS patient data and is there cause for concern?
Key questions answered around potential use of health data to train AI models under Labour’s proposalsMinisters mull allowing private firms to make profit from NHS data in AI pushUK ministers have c
Read MoreMinisters mull allowing private firms to make profit from NHS data in AI push
Anonymised data could help develop treatments, drugs and diagnostic tools but potential misuse worries expertsWhat does AI plan mean for NHS patient data and is there cause for concern?Ministers are c
Read MoreSTAT+: Jonathan Kanter on health care monopolies, and a new MA rule boosts payments
Read the online version of STAT’s email newsletter Health Care Inc.
Read MoreRFK Jr.’s MAHA Movement Obscures America’s Unhealthy Past
Medical historians say that the phrase “Make America Healthy Again” obscures a past during which this country’s people ate, smoked and drank things that mostly left them unwell.
Read MoreIs more outsourcing the remedy for NHS delays? | Letters
Responding to an article on increased input from private healthcare, John Newman calls for grants for training medical personnel, Stephen Farrington-Bell for greater productivity and Bernadette Roden
Read MoreHow to Better Manage 'No Show' Appointments
(MedPage Today) -- "So, what should we do about 11 no-show appointments?" Recently, a colleague brought to my attention a patient who had made and canceled multiple appointments in our practice --
Read MoreSTAT+: Eli Lilly scientific chief Skovronsky says Scorpion deal ‘checked all the boxes’
Eli Lilly’s chief scientific officer said the company purchased a cancer drug from the startup Scorpion Therapeutics because it "checked all the boxes.
Read MoreMost Antiviral Drugs Showed Limited or No Effects Against Flu
(MedPage Today) -- Antiviral drugs commonly used to treat non-severe influenza appeared to have little or no effect on key clinical outcomes, except for baloxavir (Xofluza), according to a systematic
Read MoreDementia Cases in the U.S. Will Surge in the Coming Decades, Researchers Say
By 2060, new dementia cases per year could double to one million because of the growing population of older Americans, a study predicts.
Read More